Bladder perfusion pharmaceutical composition, preparation method therefor and application thereof
US-2024398841-A1 · Dec 5, 2024 · US
Method to treat and prevent posterior capsule opacification
US8999370B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8999370-B2 |
| Application number | US-91379806-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 26, 2006 |
| Priority date | May 26, 2005 |
| Publication date | Apr 7, 2015 |
| Grant date | Apr 7, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides a method to treat or prevent posterior capsular opacification. The method comprises administering a therapeutically or prophylactically effective amount of a pharmaceutical composition comprising at least one kinase inhibitor. The kinase inhibitor inhibits p38 kinases, ERK kinases, and/or Src family kinases. The invention also provides an ocular device coated with at least one kinase inhibitor.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method to treat posterior capsular opacification, comprising administering a therapeutically or prophylactically effective amount of pharmaceutical composition comprising at least one kinase inhibitor, wherein the kinase inhibitor inhibits p38 kinases, ERK kinases, and/or Src family kinases. 2. The method of claim 1 , wherein the kinase inhibitor is administered on an ocular device. 3. The method of claim 2 ,…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K31/136Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8999370B2 cover?
- The invention provides a method to treat or prevent posterior capsular opacification. The method comprises administering a therapeutically or prophylactically effective amount of a pharmaceutical composition comprising at least one kinase inhibitor. The kinase inhibitor inhibits p38 kinases, ERK kinases, and/or Src family kinases. The invention also provides an ocular device coated with at leas…
- Who is the assignee on this patent?
- Menko Allyn Sue, Univ Jefferson
- What technology area does this patent fall under?
- Primary CPC classification A61K31/136. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).